Buy RVVTF by Nov 30, 2026.

RVVTF — Revive Therapeutics: The peptide lesson Big Pharma is about to learn the hard way. Eli Lilly just sued six companies for selling unapproved retatrutide. The drug hasn’t even finished Phase 3 yet, and the black-market peptide trade is already worth billions. That’s the tell. The multi-trillion-dollar peptide era is here, and the giants are scrambling because they lost control of the patents. Peacetime bucillamine rights are a $5M option. A live chemical-threat scare in the Middle East is …